About Penta
Who we are
Diversity and Inclusion
Penta ID Network
Penta Foundation Italy
Penta Foundation UK
Penta ID Innovation
Annual reports
Our Activities
News & Events
News
Press center
Penta Newsletter
Stories
Scientific Views
Penta Aperitivo Webinars
Publications
Contact us
Work with us
Vacancies
Call for services
Diversity & Inclusion
Brighter Future Award
Archivio
Early versus deferred highly active antiretroviral therapy in HIV infected infants: a European Collaborative Cohort Study.
Increasing Antiretroviral Drug Access for Children With HIV Infection.
Treatment interruption in children with HIV infection.
Does Early Treatment Provide Long Term Benefit in HIV-1 Infected Infants? Five Year Outcomes in Children Treated Before 3 Months of Age in the PENTA 7 Trial.
3TC+ABC maintains virological superiority over ZDV+3TC and ZDV+ABC beyond 5 years in children: the PENTA 5 trial
A comparison of the association of current CD4 cell count with the short-term risk of AIDS and death in HIV-infected children and adults.